News on immunohistochemistry and other tissue-based testing methods.
The center will initially use the system for prostate, and head and neck cancers and in the future will let LabCorp patients access Mount Sinai pathologists.
The digital pathology system can be used for primary diagnosis as a result of the 510(k) clearance, which followed a multicenter study conducted at five clinical sites.
The approach makes use of a microfluidic probe that allows researchers to more effectively collect data on the kinetics of antibody-target reactions.
The Boston-based company said it will use the funding in part to continue refining its artificial intelligence-powered pathology research platform.
The firm said that it will use the funding to support business activities to meet demand for its approach to clinical trial recruitment.
